Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis

NCT02182518 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG: Epinastine
DRUG: Pseudoephedrine
DRUG: Placebo

Sponsor

Boehringer Ingelheim